What Is the Role of the Intralaminar Thalamic Input to the Striatum and Its Potential Implications in Parkinson Disease?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Over the past several years, there has been an increased interest on the functional organization of the thalamic inputs to the basal ganglia.1 Of particular relevance are inputs from the intralaminar nuclei targeting the striatum (Figure).2-5 The intralaminar nuclei encompass several groups, anterior, central, and posterior, each consisting of several nuclei. The central intralaminar group, including the centromedian (CMn) and parafascicular (PF) nuclei (often combined as CMn/PF complex in primates and corresponding to the PF nucleus in rodents), provide the most abundant thalamic projections to the striatum2,6,7 and participate in parallel basal ganglia-thalamocortical circuits controlling both motor and nonmotor functions.5,8 The striatum also receives inputs from neurons in the anterior intralaminar nuclei, including the centrolateral nucleus (CL), which provides an important relay of inputs from the cerebellum to the striatum.9,10 Viral tracing studies in transgenic rodents show a highly specific pattern of thalamic inputs to subtypes of striatal projection neurons and interneurons and the interaction between thalamostriatal and corticostriatal inputs.3,11-13 Electrophysiologic recordings have provided insight into the effects of these thalamostriatal projections on attention, behavioral switching, reward responses, and motor control.14-17 The intralaminar nuclei are affected in Parkinson disease (PD).18-20 Studies in experimental models indicate that abnormal plasticity of the thalamostriatal system may contribute to motor manifestations of this disorder,21-24 thus suggesting potential therapeutic targets.25 For example, deep brain stimulation (DBS) of the CMn nucleus has been reported to improve levodopa-induced dyskinesias and freezing26,27 and tremor28,29 in patients with severe PD. Whereas the focus of this brief review is on the thalamostriatal projections from the intralaminar nuclei, the CMn and other thalamic nuclei also project to the globus pallidus (GP), substantia nigra (SN), and subthalamic nucleus (STN); these projections may also have a major role in PD.1 The CMn nucleus has also received particular interest as a target for DBS in other disorders such as intractable epilepsy,30-32 Tourette syndrome,33,34 minimal conscious state,35 and chronic pain.36 These topics have been recently reviewed37 and will not be discussed further in this study.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received May 11, 2023.
- Accepted in final form May 11, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.


